BioStem Technologies, Inc. (BSEM)
3.43
-0.14
(-3.79%)
USD |
OTCM |
Jun 10, 16:00
BioStem Technologies Total Assets (Quarterly) : 55.08M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 55.08M |
| December 31, 2025 | 50.20M |
| September 30, 2025 | 62.39M |
| June 30, 2025 | 112.61M |
| March 31, 2025 | 149.31M |
| December 31, 2024 | 58.49M |
| September 30, 2024 | 104.20M |
| June 30, 2024 | 91.19M |
| March 31, 2024 | 45.67M |
| December 31, 2023 | 14.61M |
| September 30, 2023 | 5.814M |
| June 30, 2023 | 3.306M |
| March 31, 2023 | 3.100M |
| December 31, 2022 | 3.577M |
| September 30, 2022 | 3.897M |
| June 30, 2022 | 4.538M |
| March 31, 2022 | 3.973M |
| December 31, 2021 | 2.672M |
| September 30, 2021 | 2.906M |
| June 30, 2021 | 2.615M |
| March 31, 2021 | 2.805M |
| December 31, 2020 | 2.673M |
| September 30, 2020 | 3.030M |
| June 30, 2020 | 3.126M |
| March 31, 2020 | 3.020M |
| Date | Value |
|---|---|
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 4.300M |
| September 30, 2018 | 4.286M |
| June 30, 2018 | 2.811M |
| March 31, 2018 | 3.062M |
| December 31, 2017 | 2.416M |
| September 30, 2017 | 2.754M |
| June 30, 2017 | 5.278M |
| March 31, 2017 | 5.410M |
| December 31, 2016 | 2.748M |
| September 30, 2016 | 3.118M |
| June 30, 2016 | 3.021M |
| March 31, 2016 | 2.494M |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | 0.1948M |
| March 31, 2014 | 0.1534M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 108.37M |
| CorMedix, Inc. | 815.64M |
| Eloxx Pharmaceuticals, Inc. | 8.503M |
| Cannabis Global, Inc. | 0.885M |
| Axsome Therapeutics, Inc. | 713.61M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 23.21M |
| Shareholders Equity (Quarterly) | 31.87M |
| Debt to Equity Ratio | 0.1029 |
| Current Ratio | 1.142 |
| Net Debt Paydown Yield | 0.33% |